Agios Pharm (AGIO) is a biotechnology company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Use this AGIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AGIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AGIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Agios Pharm even when a live quote feed is slow.
Latest cached year on this hub. Full AGIO income, balance, and cash tables.